Association study of susceptibility genes for late-onset Alzheimer's disease in the Japanese population

Psychiatric Genetics

Volumn 22, Issue 6, 2012, Pages 290-293

  Ohara, Tomoyuki ^a,b,c   Ninomiya, Toshiharu ^d   Hirakawa, Yoichiro ^c,d   Ashikawa, Kyota ^a   Monji, Akira ^e   Kiyohara, Yutaka ^c   Kanba, Shigenobu ^b   Kubo, Michiaki ^a  

^a RIKEN YOKOHAMA INSTITUTE   (Japan)

^b Departments of Neuropsychiatry   (United States)

^c Environmental Medicine   (United States)

^d KYUSHU UNIVERSITY   (Japan)

^e SAGA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; APOE; association study; PICALM

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; JAPAN;

EID: 84869505704     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0b013e3283586215     Document Type: Article

References (25)

1. American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., revised. ed. Washington, DC: American Psychiatric Association.
2. Beecham GW, Martin ER, Li YJ, Slifer MA, Gilbert JR, Haines JL, et al. (2009). Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. Am J Hum Genet 84:35-43.
3. Belbin O, Dunn JL, Ling Y, Morgan L, Chappell S, Beaumont H, et al. (2007). Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease. Hum Mol Genet 16:2199-2208.
4. Bettens K, Sleegers K, Van Broeckhoven C (2010). Current status on Alzheimer disease molecular genetics: from past, to present, to future. Hum Mol Genet 19:R4-R11.
5. Carrasquillo MM, Zou F, Pankratz VS,Wilcox SL, Ma L,Walker LP, et al. (2009). Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nat Genet 41:192-198.
6. Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, et al. (2010). Replication of CLU, CR1, and PICALM associations with Alzheimer disease. Arch Neurol 67:961-964.
7. Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, et al. (2011). Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions. J Alzheimer Dis 24:751-758.
8. Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, et al. (2010). Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet 19:3295-3301.
9. Harel A, Wu F, Mattson MP, Morris CM, Yao PJ (2008). Evidence for CALM in directing VAMP2 trafficking. Traffic 9:417-429.
10. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. (2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41:1088-1093.
11. Ikram MA, Liu F, Oostra BA, Hofman A, van Duijn CM, Breteler MM (2009). The GAB2 gene and the risk of Alzheimer's disease: replication and metaanalysis. Biol Psychiatry 65:995-999.
12. Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, et al. (2010). Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 67:1473-1484.
13. Kamboh MI, Minster RL, Demirci FY, Ganguli M, Dekosky ST, Lopez OL, et al. (2012). Association of CLU and PICALM variants with Alzheimer's disease. Neurobiol Aging 33:518-521.
14. Kubo M, Hata J, Ninomiya T, Matsuda K, Yonemoto K, Nakano T, et al. (2007). A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat Genet 39:212-217.
15. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41:1094-1099.
16. Lambert JC, Zelenika D, Hiltunen M, Chouraki V, Combarros O, Bullido MJ, et al. (2011). Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol Aging 32:e11-e15.
17. Liang WS, Chen K, Lee W, Sidhar K, Corneveaux JJ, Allen AN, et al. (2011). Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEepsilon4 carriers. Neuroimage 54:1896-1902.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944.
19. Miyashita A, Arai H, Asada T, Imagawa M, Shoji M, Higuchi S, et al. (2009). GAB2 is not associated with late-onset Alzheimer's disease in Japanese. Eur J Hum Genet 17:682-686.
20. Ohara T, Doi Y, Ninomiya T, Hirakawa Y, Hata J, Iwaki T, et al. (2011). Glucose tolerance status and risk of dementia in the community: the Hisayama Study. Neurology 77:1126-1134.
21. Ohnishi Y, Tanaka T, Ozaki K, Yamada R, Suzuki H, Nakamura Y (2001). A highthroughput SNP typing system for genome-wide association studies. J Hum Genet 46:471-477.
22. Purcell S, Cherny SS, Sham PC (2003). Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-150.
23. Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, et al. (2007). GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 54:713-720.
24. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. (2010). Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303:1832-1840.
25. Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM, Van Broeckhoven C, et al. (1998). Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 55:964-968.